tiprankstipranks
Argenx Se (DE:1AEA)
MUNICH:1AEA

Argenx Se Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
10Ratings
9 Buy
1 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Argenx
Se
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1AEA Stock Price Prediction

Average Price Target

€438.60
▲(21.16% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is €438.60 with a high forecast of €484.04 and a low forecast of €348.60. The average price target represents a 21.16% change from the last price of €362.00.
Highest Price Target€484.04Average Price Target€438.60Lowest Price Target€348.60
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Jefferies
€368.89
Buy
1.90%
Upside
Reiterated
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and US Physical Therapy (NYSE: USPH)
Raymond James
Buy
Reiterated
Expert Believes "The Trial Will Hit its Primary Efficacy Endpoint" - Raymond James Bullish on argenx SE (ARGX) Ahead of efgartigimod Phase 3 ReadoutHe believes the trial will hit its primary efficacy endpoint given (1) its well accepted that IgG reduction leads to higher platelet levels, (2) efgar drove platelet responses (some durable) in Ph 2, and (3) the Ph 3 design is optimized for success.
Cowen & Co.
Buy
Reiterated
Argenx's SC MG data near best-case scenario, says CowenArgenx's SC MG data near best-case scenario, says Cowen
Wells Fargo
€399.46
Buy
10.35%
Upside
Reiterated
Argenx shares could be up 5%-10% on subQ Vyvgart data, says Wells FargoArgenx shares could be up 5%-10% on subQ Vyvgart data, says Wells Fargo
Credit Suisse
€325.07
Hold
-10.20%
Downside
Reiterated
UPDATE: argenx SE (ARGX) PT Lowered to $319 at Credit SuisseCredit Suisse analyst Tiago Fauth lowered the price target on argenx SE (NASDAQ: ARGX) to $319.00 (from $346.00) while maintaining a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1AEA Stock Forecast FAQ

What is DE:1AEA’s average 12-month price target, according to analysts?
Based on analyst ratings, Argenx Se’s 12-month average price target is €438.60.
    What is DE:1AEA’s upside potential, based on the analysts’ average price target?
    Argenx Se has 21.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DE:1AEA a Buy, Sell or Hold?
          Argenx Se has a conensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Argenx Se’s price target?
            The average price target for Argenx Se is €438.60. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is €484.04 ,the lowest forecast is €348.60. The average price target represents 21.16% Increase from the current price of €362.
              What do analysts say about Argenx Se?
              Argenx Se’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis